Nutrition

USA

The prostate is the gland below a man's bladder that produces fluid for semen. Prostate cancer is the third most common cause of death from cancer in men of all ages. It is rare in men younger than 40. Levels of a substance called prostate specific antigen (PSA) is often high in men with prostate cancer. However, PSA can also be high with other prostate conditions. Since the PSA test became common, most prostate cancers are found before they cause symptoms. Symptoms of prostate cancer may include Problems passing urine, such as pain, difficulty starting or stopping the stream, or dribbling Low back pain Pain with ejaculation Prostate cancer treatment often depends on the stage of the cancer. How fast the cancer grows and how different it is from surrounding tissue helps determine the stage. Treatment may include surgery, radiation therapy, chemotherapy or control of hormones that affect the cancer.

earthclinic.com

Creatine is a naturally occurring amino acid (protein building block) found mainly in muscles. Fifty percent of creatine in our bodies is ingested through the foods we eat while the other 50% is made in the liver, kidney, and pancreas. Roughly one-third i

Protein plays a litany of roles in living systems: structural elements, peptide hormones, cell recognition, antibodies… the list is staggering and continues to grow as our understanding of biology expands. What, however, is the role of dietary protein i

A review of Dr. T. Colin Campbell's China Study book.

Dark Chocolate, Other Cocoa-Rich Foods May Lower Blood Pressure Better Than Tea April 9, 2007 -- A chocolate treat may be better than green or black tea at keeping high blood pressure in check. A new study suggests that dark chocolate and other coco

Herbal Medicine Forskolin May Reduce Urinary Tract Infection April 9, 2007 -- Forskolin, an herbal medicine made from the Asiatic coleus plant, may help treat urinary tract infection. That's according to preliminary tests done in mice. The resear

Erbitux (Cetuximab), a new drug which is used in combination with chemotherapy, increases overall survival in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck, according to ImClone, the company which introduced the dr

Wyeth Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted a new "fast track" designation for temsirolimus (CCI-779), an investigational mTOR kinase inhibitor, in the first-line treatment of poor-prognosis patients